| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3981626
[patent_doc_number] => 05948890
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-07
[patent_title] => 'Human G-protein receptor HPRAJ70'
[patent_app_type] => 1
[patent_app_number] => 9/053303
[patent_app_country] => US
[patent_app_date] => 1998-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14021
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/948/05948890.pdf
[firstpage_image] =>[orig_patent_app_number] => 053303
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/053303 | Human G-protein receptor HPRAJ70 | Mar 31, 1998 | Issued |
Array
(
[id] => 1340809
[patent_doc_number] => 06589935
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-08
[patent_title] => 'Insulin receptor tyrosine kinase substrate'
[patent_app_type] => B1
[patent_app_number] => 09/046572
[patent_app_country] => US
[patent_app_date] => 1998-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23818
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/589/06589935.pdf
[firstpage_image] =>[orig_patent_app_number] => 09046572
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/046572 | Insulin receptor tyrosine kinase substrate | Mar 22, 1998 | Issued |
| 09/046316 | CYTOKINE FAMILY MEMBER 2-21 | Mar 22, 1998 | Abandoned |
Array
(
[id] => 1515439
[patent_doc_number] => 06420529
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Genetic selection method for identifying ligands for transmembrane proteins'
[patent_app_type] => B1
[patent_app_number] => 09/035233
[patent_app_country] => US
[patent_app_date] => 1998-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5808
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420529.pdf
[firstpage_image] =>[orig_patent_app_number] => 09035233
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/035233 | Genetic selection method for identifying ligands for transmembrane proteins | Mar 4, 1998 | Issued |
Array
(
[id] => 4234110
[patent_doc_number] => 06143519
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-07
[patent_title] => 'Human endothelin-bombesin receptor'
[patent_app_type] => 1
[patent_app_number] => 9/030970
[patent_app_country] => US
[patent_app_date] => 1998-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 14325
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/143/06143519.pdf
[firstpage_image] =>[orig_patent_app_number] => 030970
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/030970 | Human endothelin-bombesin receptor | Feb 25, 1998 | Issued |
| 08/973178 | METHOD OF EXPRESSING AND SECRETING SOLUBLE EXTRACELLULAR DOMAINS OF HUMAIN GONADOTROPIN HORMONE RECEPTORS | Feb 9, 1998 | Abandoned |
| 09/021233 | CHIMERIC HETEROMULTIMER ADHESINS | Feb 9, 1998 | Abandoned |
Array
(
[id] => 1433284
[patent_doc_number] => 06340574
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-22
[patent_title] => 'Regulated autocrine growth of mammalian cells'
[patent_app_type] => B1
[patent_app_number] => 09/000442
[patent_app_country] => US
[patent_app_date] => 1998-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 8739
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/340/06340574.pdf
[firstpage_image] =>[orig_patent_app_number] => 09000442
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/000442 | Regulated autocrine growth of mammalian cells | Jan 25, 1998 | Issued |
| 09/007886 | APO-2 LIGAND | Jan 14, 1998 | Abandoned |
Array
(
[id] => 4310956
[patent_doc_number] => 06242213
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Isolated DNA molecules encoding RANK-L'
[patent_app_type] => 1
[patent_app_number] => 8/995659
[patent_app_country] => US
[patent_app_date] => 1997-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28096
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242213.pdf
[firstpage_image] =>[orig_patent_app_number] => 995659
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/995659 | Isolated DNA molecules encoding RANK-L | Dec 21, 1997 | Issued |
Array
(
[id] => 4176992
[patent_doc_number] => 06084092
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => '.beta.(1-3)-glucan diagnostic assays'
[patent_app_type] => 1
[patent_app_number] => 8/990125
[patent_app_country] => US
[patent_app_date] => 1997-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 9775
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/084/06084092.pdf
[firstpage_image] =>[orig_patent_app_number] => 990125
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/990125 | .beta.(1-3)-glucan diagnostic assays | Dec 11, 1997 | Issued |
| 08/990155 | ACTIVATION OF TRANSCRIPTION FACTOR COMPLEX BY UNDERIVATIZED, AQUEOUS SOLUBLE B(1-3) GLUCAN | Dec 11, 1997 | Abandoned |
Array
(
[id] => 4171855
[patent_doc_number] => 06083753
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'Soluble human prolactin receptors'
[patent_app_type] => 1
[patent_app_number] => 8/970428
[patent_app_country] => US
[patent_app_date] => 1997-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 17049
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/083/06083753.pdf
[firstpage_image] =>[orig_patent_app_number] => 970428
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/970428 | Soluble human prolactin receptors | Nov 13, 1997 | Issued |
Array
(
[id] => 3991993
[patent_doc_number] => 05985608
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Actin-binding polypeptides and nucleic acids encoding the same'
[patent_app_type] => 1
[patent_app_number] => 8/962284
[patent_app_country] => US
[patent_app_date] => 1997-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 13
[patent_no_of_words] => 35217
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985608.pdf
[firstpage_image] =>[orig_patent_app_number] => 962284
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/962284 | Actin-binding polypeptides and nucleic acids encoding the same | Oct 30, 1997 | Issued |
| 08/943452 | MAMMALIAN POLYCATION-SENSING RECEPTOR AND METHODS OF USE THEREOF | Oct 1, 1997 | Abandoned |
Array
(
[id] => 3989410
[patent_doc_number] => 05891673
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Lck binding protein'
[patent_app_type] => 1
[patent_app_number] => 8/942423
[patent_app_country] => US
[patent_app_date] => 1997-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 18937
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891673.pdf
[firstpage_image] =>[orig_patent_app_number] => 942423
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/942423 | Lck binding protein | Sep 30, 1997 | Issued |
| 08/941354 | NOVEL MOLECULES OF THE TRANSMEMBRANE SEGMENT TRANSPORTER SUPERFAMILY AND USES THEREFOR | Sep 29, 1997 | Abandoned |
Array
(
[id] => 3949265
[patent_doc_number] => 05977298
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Calcitonin derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/934741
[patent_app_country] => US
[patent_app_date] => 1997-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 18672
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 385
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977298.pdf
[firstpage_image] =>[orig_patent_app_number] => 934741
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/934741 | Calcitonin derivatives | Sep 21, 1997 | Issued |
Array
(
[id] => 4284478
[patent_doc_number] => 06210921
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'CAR: a novel coxsackievirus and adenovirus receptor'
[patent_app_type] => 1
[patent_app_number] => 8/928383
[patent_app_country] => US
[patent_app_date] => 1997-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 27805
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/210/06210921.pdf
[firstpage_image] =>[orig_patent_app_number] => 928383
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/928383 | CAR: a novel coxsackievirus and adenovirus receptor | Sep 11, 1997 | Issued |
Array
(
[id] => 4128719
[patent_doc_number] => 06033871
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-07
[patent_title] => 'DNA molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby'
[patent_app_type] => 1
[patent_app_number] => 8/922635
[patent_app_country] => US
[patent_app_date] => 1997-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 20628
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/033/06033871.pdf
[firstpage_image] =>[orig_patent_app_number] => 922635
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/922635 | DNA molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby | Sep 2, 1997 | Issued |